SINT earnings analysis
What we found in SINT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, MD&A, or segment disclosures, so revenue, margins, EPS, cash flow, working-capital trends, and year-over-year comparisons cannot be assessed from the provided filing text. Controls were effective as of June 30, 2026, and the company reported no material pending legal proceedings. The principal newly disclosed item is a CFO change-in-control agreement that could create cash severance, healthcare, and equity-vesting obligations, including a 2-times lump-sum formula and up to 36 months of medical-plan payments.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Disclosure controls deemed effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026, the end of the reporting period.
- No material pending litigation
- The company reported no material pending legal proceeding as of the filing date.
- Repurchase authorization remains available
- The share repurchase authorization permits up to $500,000 of purchases; $366,935 remained available as of June 30, 2026, although no shares were repurchased during the quarter.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Potential change-in-control costs
- The August 7, 2026 change-in-control agreement provides the CFO with a lump-sum payment equal to 2 times the sum of annual base salary and a specified annual bonus amount following certain qualifying terminations, plus other benefits.
- Severance and equity acceleration
- The CFO agreement may require monthly medical-plan continuation payments for up to 36 months following a qualifying termination and may accelerate vesting of outstanding time-based equity awards.
- No new formal risk-factor changes
- The filing states that there have been no material changes from the risk factors in the 2025 Form 10-K filed March 20, 2026; therefore, no new formal risk-factor changes were identified in the supplied report.
What they said about what is next.
No quantitative revenue or EPS outlook was disclosed in the supplied 10-Q extract. The filing does not provide an earnings outlook or update to prior guidance.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 15, 2026
- SINTX Technologies reported a modest revenue increase of 3% in Q1 2026 compared to Q1 2025, with total revenue at $300,000. The company's gross profit margins improved slightly, and while losses increased, management…
- 10-K · March 20, 2026
- SINTX Technologies, Inc. reported a net loss of $10.4 million for the year ended December 31, 2025, with total revenue declining by 65% to $1.018 million due to strategic shifts away from low-margin OEM contracts. The…
- 10-Q · November 12, 2025
- SINTX Technologies reported significantly lower Q3 2025 results, with revenue of $208,000, down 74% year-over-year, and a net loss of $3.54 million, compared to a loss of $6.24 million in 2024. The decline was…
- 10-Q · August 14, 2025
- SINT reported a significant decline in revenue in Q2 2025, totaling $151,000, which fell short of the $400,000 consensus estimate. The company's gross margin was down to 37.8%, and it reported a diluted EPS of -0.91,…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing SINT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever